Juno Therapeutics vs Primogene
Juno Therapeutics vs Primogene, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Juno Therapeutics is on 66/100 and Primogene on 39/100.
Where each one leads
Juno Therapeutics
- our overall score: 66/100 against 39/100
- funding raised: $317M against $4.1M
Primogene
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Juno Therapeutics | Primogene |
|---|---|---|
| What it is | Biotechnology company focused on developing cancer immunotherapies. | Enabling sustainable and scalable manufacturing of complex, high-value biomolecules through enzymatic biomanufacturing. |
| Category | Biotechnology, Pharmaceuticals, Cancer Immunotherapy, Cart | Biotechnology, Health, Nutrition, Personal Care |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2013 | 2023 |
| Headquarters | Seattle, United States | Leipzig, Germany |
| Status | Active | Active |
Size, funding and growth
| Measure | Juno Therapeutics | Primogene |
|---|---|---|
| Total funding | $317M | $4.1M |
| Latest round | Series B | Seed |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Juno Therapeutics | Primogene |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 39/100 |
| Traction | 40/100 | 33/100 |
| Team | 90/100 | 30/100 |
| Community | 15/100 | Not published |
| Search visibility | 15/100 | 13/100 |
| Quality | 87/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (21/100) |
Juno Therapeutics vs Primogene: common questions
Which is better, Juno Therapeutics or Primogene?
On our 0-100 score Juno Therapeutics rates higher (66/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Juno Therapeutics and Primogene compare on the numbers?
Juno Therapeutics leads on our overall score (66/100 against 39/100), funding raised ($317M against $4.1M).
Read the full Juno Therapeutics review and pricing or the Primogene review and pricing. You can also browse other Juno Therapeutics alternatives we track.